1921
Volume 85, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Nicaragua was the first developing nation to implement universal infant rotavirus immunization with the pentavalent rotavirus vaccine (RV5). Initial studies of vaccine effectiveness in Nicaragua and other developing nations have focused on the prevention of hospitalizations and severe rotavirus diarrhea. However, rotavirus diarrhea is more commonly treated in the primary care setting, with only 1–3% of rotavirus cases receiving hospital care. We measured the prevalence of rotavirus infection in primary care clinics in León, Nicaragua, after introduction of the immunization program. In the post-vaccine period, 3.5% (95% confidence interval = 1.9–5.8) of children seeking care for diarrhea tested positive for rotavirus. A high diversity of rotavirus genotypes was encountered among the few positive samples. In conclusion, rotavirus was an uncommon cause of childhood diarrhea in this primary care setting after implementation of a rotavirus immunization program.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.2011.11-0401
2011-11-01
2018-12-11
Loading full text...

Full text loading...

/deliver/fulltext/14761645/85/5/957.html?itemId=/content/journals/10.4269/ajtmh.2011.11-0401&mimeType=html&fmt=ahah

References

  1. Glass RI, Parashar UD, Bresee JS, Turcios R, Fischer TK, Widdowson MA, Jiang B, Gentsch JR, , 2006. Rotavirus vaccines: current prospects and future challenges. Lancet 368: 323332.[Crossref] [Google Scholar]
  2. Guerrant RL, Schorling JB, McAuliffe JF, de Souza MA, , 1992. Diarrhea as a cause and an effect of malnutrition: diarrhea prevents catch-up growth and malnutrition increases diarrhea frequency and duration. Am J Trop Med Hyg 47: 2835. [Google Scholar]
  3. Niehaus MD, Moore SR, Patrick PD, Derr LL, Lorntz B, Lima AA, Guerrant RL, , 2002. Early childhood diarrhea is associated with diminished cognitive function 4 to 7 years later in children in a northeast Brazilian shantytown. Am J Trop Med Hyg 66: 590593. [Google Scholar]
  4. Lorntz B, Soares AM, Moore SR, Pinkerton R, Gansneder B, Bovbjerg VE, Guyatt H, Lima AM, Guerrant RL, , 2006. Early childhood diarrhea predicts impaired school performance. Pediatr Infect Dis J 25: 513520.[Crossref] [Google Scholar]
  5. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM, ; Rotavirus Efficacy and Safety Trial (REST) Study Team, 2006. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354: 2333.[Crossref] [Google Scholar]
  6. Patel M, Pedreira C, De Oliveira LH, Tate J, Orozco M, Mercado J, Gonzalez A, Malespin O, Amador JJ, Umaña J, Balmaseda A, Perez MC, Gentsch J, Kerin T, Hull J, Mijatovic S, Andrus J, Parashar U, , 2009. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA 301: 22432251.[Crossref] [Google Scholar]
  7. Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gillard PH, Cheuvart BB, Han HH, Neuzil KM, , 2010. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 362: 289298.[Crossref] [Google Scholar]
  8. Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, Podder G, Vu DT, Le TP, Luby SP, Le HT, Coia ML, Lewis K, Rivers SB, Sack DA, Schödel F, Steele AD, Neuzil KM, Ciarlet M, , 2010. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 376: 615623.[Crossref] [Google Scholar]
  9. Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, Binka FN, Steele AD, Laserson KF, Ansah NA, Levine MM, Lewis K, Coia ML, Attah-Poku M, Ojwando J, Rivers SB, Victor JC, Nyambane G, Hodgson A, Schödel F, Ciarlet M, Neuzil KM, , 2010. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 376: 606614.[Crossref] [Google Scholar]
  10. Espinoza F, Paniagua M, Hallander H, Hedlund KO, Svensson L, , 1997. Prevalence and characteristics of severe rotavirus infections in Nicaraguan children. Ann Trop Paediatr 17: 2532.[Crossref] [Google Scholar]
  11. Becker-Dreps S, Paniagua M, Dominik R, Cao H, Shah NK, Morgan DR, Moreno G, Espinoza F, , 2011. Changes in childhood diarrhea incidence in Nicaragua following 3 years of universal rotavirus immunization. Pediatr Infect Dis J 30: 243247.[Crossref] [Google Scholar]
  12. Espinoza F, , 2004. Rotavirus in pediatric gastroenteritis in Nicaraguan children. PhD thesis. Karolinska Institutet, Stockholm, Sweden. [Google Scholar]
  13. Iturriza-Gómara M, Kang G, Gray J, , 2004. Rotavirus genotyping: keeping up with an evolving population of human rotaviruses. J Clin Virol 31: 259265.[Crossref] [Google Scholar]
  14. Parashar UD, Glass RI, , 2009. Rotavirus vaccines—early success, remaining questions. N Engl J Med 360: 10631065.[Crossref] [Google Scholar]
  15. O'Ryan M, Díaz J, Mamani N, Navarrete M, Vallebuono C, , 2007. Impact of rotavirus infections on outpatient clinic visits in Chile. Pediatr Infect Dis J 26: 4145.[Crossref] [Google Scholar]
  16. Carmona RC, Timenetsky Mdo C, da Silva FF, Granato CF, , 2004. Characterization of rotavirus strains from hospitalized and outpatient children with acute diarrhoea in São Paulo, Brazil. J Med Virol 74: 166172.[Crossref] [Google Scholar]
  17. Cama RI, Parashar UD, Taylor DN, Hickey T, Figueroa D, Ortega YR, Romero S, Perez J, Sterling CR, Gentsch JR, Gilman RH, Glass RI, , 1999. Enteropathogens and other factors associated with severe disease in children with acute watery diarrhea in Lima, Peru. J Infect Dis 179: 11391144.[Crossref] [Google Scholar]
  18. Pérez-Schael I, González R, Fernández R, Alfonzo E, Inaty D, Boher Y, Sarmiento L, , 1999. Epidemiological features of rotavirus infection in Caracas, Venezuela: implications for rotavirus immunization programs. J Med Virol 59: 520526.[Crossref] [Google Scholar]
  19. Espinoza F, Bucardo F, Paniagua M, Svensson L, Hallander HO, Bondeson K, , 2006. Shifts of rotavirus G and P types in Nicaragua—2001–2003. Pediatr Infect Dis J 25: 10781080.[Crossref] [Google Scholar]
  20. Bourdett-Stanziola L, Ortega-Barria E, Espinoza F, Bucardo F, Jimenez C, Ferrera A, , 2011. Rotavirus genotypes in Costa Rica, Nicaragua, Honduras and the Dominican Republic. Intervirology 54: 4952.[Crossref] [Google Scholar]
  21. Bourdett-Stanziola L, Jiménez C, Ortega-Barria E, , 2008. Diversity of human rotavirus G and P genotypes in Panama, Costa Rica, and the Dominican Republic. Am J Trop Med Hyg 79: 921924. [Google Scholar]
  22. Gentsch JR, Laird AR, Bielfelt B, Griffin DD, Banyai K, Ramachandran M, Jain V, Cunliffe NA, Nakagomi O, Kirkwood CD, Fischer TK, Parashar UD, Bresee JS, Jiang B, Glass RI, , 2005. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis 192 (Suppl 1): S146S159.[Crossref] [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2011.11-0401
Loading
/content/journals/10.4269/ajtmh.2011.11-0401
Loading

Data & Media loading...

  • Received : 22 Jun 2011
  • Accepted : 19 Aug 2011

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error